Seasonal Influenza Global Market Report 2025

Description

Seasonal influenza, commonly known as the flu, is a contagious respiratory infection caused by influenza viruses that circulate worldwide, primarily during specific seasons (typically fall and winter in temperate regions). It spreads through respiratory droplets when an infected person coughs, sneezes, or talks. Seasonal influenza causes widespread illness and can lead to severe complications, particularly in vulnerable populations such as the elderly and individuals with weakened immune systems.

The primary types of seasonal influenza include influenza A, B, C, and D viruses. Influenza A virus is a subtype that infects humans and various animals, often responsible for seasonal flu outbreaks and pandemics. Treatments are administered through different routes, including parenteral, oral, and other methods. These treatments are distributed through various channels, such as hospitals, government and institutional supply, pharmacies, and online platforms. Treatment options include antivirals, neuraminidase inhibitors, vaccinations, and other therapeutic approaches.

The seasonal influenza market research report is one of a series of new reports from The Business Research Company that provides seasonal influenza market statistics, including the seasonal influenza industry global market size, regional shares, competitors with the seasonal influenza market share, detailed seasonal influenza market segments, market trends, and opportunities, and any further data you may need to thrive in the seasonal influenza industry. This seasonal influenza market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The seasonal influenza market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.88 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to the rising prevalence of influenza, the increasing elderly population, the growing prevalence of infectious and chronic diseases, the rising burden of influenza-related illness, and the surge in respiratory infections.

The seasonal influenza market size is expected to see rapid growth in the next few years. It will grow to $18.55 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to the increasing demand for oral drug solutions, expanding research and development activities, rising vaccination rates, improving healthcare infrastructure, and the growing demand for retail pharmacies. Major trends include advancements in treatment options, technological innovations, progress in vaccine development, the adoption of mRNA technology, and the integration of digital health solutions for monitoring and diagnosis.

The rising prevalence of respiratory infections is expected to drive the growth of the seasonal influenza market in the coming years. Respiratory infections, caused by viruses or bacteria, affect the respiratory system, including the sinuses, throat, airways, and lungs. Several factors contribute to the increasing prevalence of these infections, including air pollution, climate changes, weakened immune responses, and the ease of viral transmission in crowded or poorly ventilated areas. Seasonal influenza treatments play a crucial role in preventing or reducing the severity of respiratory infections by targeting the influenza virus and managing symptoms that may lead to secondary infections. For example, in October 2024, the UK Health Security Agency reported a 10.7% year-over-year increase in tuberculosis (TB) cases in England, rising from 4,380 cases in 2022 to 4,850 cases in 2023. As a result, the rising incidence of respiratory infections is expected to drive the expansion of the seasonal influenza market.

Leading companies in the seasonal influenza market are advancing treatment options through innovations such as combination vaccines, which enhance immunity by targeting multiple strains of the virus, improving effectiveness, and reducing the need for frequent vaccinations. Combination vaccines offer protection against multiple diseases or viral strains with a single injection, minimizing the number of shots required for immunization. For instance, in October 2023, Moderna, Inc., a US-based biotechnology company, announced positive interim Phase 1/2 trial results for mRNA-1083, an investigational combination vaccine designed to protect against both influenza and COVID-19. Developed to enhance compliance, streamline administration, and improve convenience for individuals and healthcare systems, mRNA-1083 is being evaluated for safety and immunogenicity in comparison to standard flu vaccines Fluarix (for individuals aged 50-64) and Fluzone HD (for individuals aged 65-79), as well as against the Spikevax booster.

In February 2023, Clover Biopharmaceuticals Ltd., a China-based commercial-stage biotechnology company, partnered with Adimmune Corporation to distribute AdimFlu-S (QIS), the only imported quadrivalent seasonal influenza vaccine approved for individuals aged three and older in mainland China. Adimmune Corporation is a Taiwan-based company specializing in vaccine development and production.

Major players in the seasonal influenza market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., Daiichi Sankyo Company Limited, CSL Limited, Genentech Inc., Shionogi & Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Bharat Biotech International Limited, Vaxart Inc., Inovio Pharmaceuticals Inc., SK bioscience Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., Altimmune Inc.

North America was the largest region in the seasonal influenza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in seasonal influenza report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the seasonal influenza market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The seasonal influenza market consists of revenues earned by entities by provide services such flu vaccination services, specialized care for high-risk populations, telemedicine services, and proactive treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The seasonal influenza market consists of sales of medications, diagnostic kits, preventive and supportive products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Seasonal Influenza Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on seasonal influenza market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for seasonal influenza ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The seasonal influenza market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Influenza A Virus; Influenza B Virus; Influenza C Virus; Influenza D Virus
2) By Route Of Administration: Parenteral; Oral; Other Route Of Administrations
3) By Distribution Channel: Hospital; Government and institutional supply; Pharmacy; Online
4) By Treatment: Antiviral; Neuraminidase Inhibitors; Vaccination; Other Treatments
Subsegments:
1) By Influenza A Virus: Subtype H1N1; Subtype H3N2; Other Subtypes
2) By Influenza B Virus: Lineage Victoria; Lineage Yamagata
3) By Influenza C Virus: Seasonal C Virus; Non-seasonal C Virus
4) By Influenza D Virus: Animal-associated Influenza D
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Sanofi S.A.; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34151

1. Executive Summary

2. Seasonal Influenza Market Characteristics

3. Seasonal Influenza Market Trends And Strategies

4. Seasonal Influenza Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Seasonal Influenza Growth Analysis And Strategic Analysis Framework

5.1. Global Seasonal Influenza PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Seasonal Influenza Market Growth Rate Analysis
5.4. Global Seasonal Influenza Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Seasonal Influenza Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Seasonal Influenza Total Addressable Market (TAM)

6. Seasonal Influenza Market Segmentation

6.1. Global Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Influenza A Virus
Influenza B Virus
Influenza C Virus
Influenza D Virus
6.2. Global Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
Other Route Of Administrations
6.3. Global Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Government and institutional supply
Pharmacy
Online
6.4. Global Seasonal Influenza Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiviral
Neuraminidase Inhibitors
Vaccination
Other Treatments
6.5. Global Seasonal Influenza Market, Sub-Segmentation Of Influenza A Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subtype H1N1
Subtype H3N2
Other Subtypes
6.6. Global Seasonal Influenza Market, Sub-Segmentation Of Influenza B Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lineage Victoria
Lineage Yamagata
6.7. Global Seasonal Influenza Market, Sub-Segmentation Of Influenza C Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Seasonal C Virus
Non-seasonal C Virus
6.8. Global Seasonal Influenza Market, Sub-Segmentation Of Influenza D Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Animal-associated Influenza D

7. Seasonal Influenza Market Regional And Country Analysis

7.1. Global Seasonal Influenza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Seasonal Influenza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Seasonal Influenza Market

8.1. Asia-Pacific Seasonal Influenza Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Seasonal Influenza Market

9.1. China Seasonal Influenza Market Overview
9.2. China Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Seasonal Influenza Market

10.1. India Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Seasonal Influenza Market

11.1. Japan Seasonal Influenza Market Overview
11.2. Japan Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Seasonal Influenza Market

12.1. Australia Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Seasonal Influenza Market

13.1. Indonesia Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Seasonal Influenza Market

14.1. South Korea Seasonal Influenza Market Overview
14.2. South Korea Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Seasonal Influenza Market

15.1. Western Europe Seasonal Influenza Market Overview
15.2. Western Europe Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Seasonal Influenza Market

16.1. UK Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Seasonal Influenza Market

17.1. Germany Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Seasonal Influenza Market

18.1. France Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Seasonal Influenza Market

19.1. Italy Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Seasonal Influenza Market

20.1. Spain Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Seasonal Influenza Market

21.1. Eastern Europe Seasonal Influenza Market Overview
21.2. Eastern Europe Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Seasonal Influenza Market

22.1. Russia Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Seasonal Influenza Market

23.1. North America Seasonal Influenza Market Overview
23.2. North America Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Seasonal Influenza Market

24.1. USA Seasonal Influenza Market Overview
24.2. USA Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Seasonal Influenza Market

25.1. Canada Seasonal Influenza Market Overview
25.2. Canada Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Seasonal Influenza Market

26.1. South America Seasonal Influenza Market Overview
26.2. South America Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Seasonal Influenza Market

27.1. Brazil Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Seasonal Influenza Market

28.1. Middle East Seasonal Influenza Market Overview
28.2. Middle East Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Seasonal Influenza Market

29.1. Africa Seasonal Influenza Market Overview
29.2. Africa Seasonal Influenza Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Seasonal Influenza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Seasonal Influenza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Seasonal Influenza Market Competitive Landscape And Company Profiles

30.1. Seasonal Influenza Market Competitive Landscape
30.2. Seasonal Influenza Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Seasonal Influenza Market Other Major And Innovative Companies

31.1. Novartis International AG
31.2. GlaxoSmithKline plc
31.3. Merck KGaA
31.4. Moderna Inc.
31.5. Boehringer Ingelheim International GmbH
31.6. Sinovac Biotech Ltd.
31.7. Daiichi Sankyo Company Limited
31.8. CSL Limited
31.9. Genentech Inc.
31.10. Shionogi & Co. Ltd.
31.11. Emergent BioSolutions Inc.
31.12. Novavax Inc.
31.13. BioCryst Pharmaceuticals Inc.
31.14. Bharat Biotech International Limited
31.15. Vaxart Inc.

32. Global Seasonal Influenza Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Seasonal Influenza Market

34. Recent Developments In The Seasonal Influenza Market

35. Seasonal Influenza Market High Potential Countries, Segments and Strategies

35.1 Seasonal Influenza Market In 2029 - Countries Offering Most New Opportunities
35.2 Seasonal Influenza Market In 2029 - Segments Offering Most New Opportunities
35.3 Seasonal Influenza Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer